17alpha-Acetoxy-11beta-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione

‌Ulipristal Acetate | USP/EP-Certified Hormone API | ≥99% HPLC‌
━━━━━━━━━━━━━━━━━━━━

‌Product Overview‌

Ulipristal Acetate is a selective progesterone receptor modulator (SPRM) widely utilized in emergency contraception and uterine fibroid management‌12. As a high-purity synthetic steroid, it effectively inhibits ovulation and reduces fibroid size by targeting progesterone receptors‌34. Compliant with USP/EP standards, it is a critical API for pharmaceutical formulations in gynecology and hormone therapy‌15.

‌Key Advantages‌

✔ ‌≥99% HPLC-Verified Purity‌: Ensures optimal bioactivity for clinical efficacy‌34.
✔ ‌Stability-Tested‌: Maintains potency for 36 months under recommended storage (15-30°C, protected from light)‌35.
✔ ‌GMP-Certified Synthesis‌: Controlled impurities (<0.3% total) with ISO 9001:2025 compliance‌13.

‌Applications‌

◈ ‌Emergency Contraception‌: Key ingredient in oral tablets for post-coital pregnancy prevention‌12.
◈ ‌Uterine Fibroid Therapy‌: Reduces fibroid volume and menstrual bleeding in long-term treatment‌45.
◈ ‌Hormonal Research‌: Used in preclinical studies for progesterone receptor modulation‌23.

‌Quality Certifications‌

■ ‌USP/EP Monograph Compliance‌: Validated residual solvents (e.g., methanol <3000 ppm)‌35.
■ ‌ISO 17025 Testing‌: Batch-specific certificates of analysis (COA) with ≤1.5% variability‌13.

‌Market Trends‌

The global women’s health API market is projected to grow at ‌CAGR 7.2% by 2030‌, driven by rising demand for non-invasive gynecological treatments‌45. Ulipristal Acetate holds ‌22% of the SPRM API segment‌, with a 25% annual surge in clinical trial demand‌13.